Gastroenterology

General Rheumatology   

Questions discussed in this category



Does this presentation fall within the autoinflammatory spectrum, and is it consistent with FMF or would you consider another cytokine-driven process?...

Do you generally recommend anti-diarrheals, dietary modifications, or consider this an unacceptable side effect and move to other therapies? 

How do you approach ongoing screening for TB in patients with history of treated latent TB, but have ongoing use of DMARDs and/or biologics given quan...

For example, in patients who are HbSAg negative, anti-HBc positive and HbSAb negative, does vaccination reduce reactivation risk?

How do you approach de-escalation or justify therapy maintenance? Do you have tiers of medications that you attempt to de-escalate first? In one parti...

Would the etiology of the thrombocytosis play a role in your decision-making?

When it seems fairly certain that this is a drug effect is it something that can just be monitored or requires a change in approach?


Papers discussed in this category


Arthritis Rheumatol, 2016 Jan

Arthritis care & research, 2017-03

Clin Exp Dermatol, 2018 May 24

Annals of the rheumatic diseases, 2015-06

Neth J Med,

Medicine (Baltimore),

Autoimmun Rev, 2012 Nov 30

Medizinische Klinik (Munich, Germany : 1983), 2002-11-15

Journal for scientific research. Medical sciences, 2001 Apr

Arthritis & rheumatology (Hoboken, N.J.), 2017-10

Therapeutic drug monitoring, 2022 Jun 01

The Journal of infection, 2011-11

Alimentary pharmacology & therapeutics, 2006 Nov 15

Journal of tropical medicine, 2017 Feb 26